Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage

Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage

Aim. To evaluate the efficacy of Remaxol used to treat post-withdrawal disorders in alcoholic patients with comorbid liver damage. Subjects and methods. The authors assessed the severity of clinical parameters, such as pathological craving and anhedonia, biochemical parameters (bilirubin, alanine am...

Full description

Bibliographic Details
Main Authors: N A Bokhan, A F Abolonin, I É Ankudinova, D I Kurgak, A I Mandel'
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2012-10-01
Series:Терапевтический архив
Subjects:
alcoholism
remaxol
metabolic disturbance
bilirubin
alanine aminotransferase
aspartate aminotransferase
anxiety
anhedonia
pathological craving for alcohol
comorbidity
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31124

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31124

Similar Items